Status:
COMPLETED
Identification of Prostate Cancer Genes
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Prostate Cancer
Eligibility:
All Genders
18-100 years
Brief Summary
This study will identify genes that predispose men to prostate cancer and affect the rate and type of disease spread, the aggressiveness of the disease, and the long-term outcome. Several studies show...
Detailed Description
The notion that there are prostate cancer susceptibility genes has since been suggested by case-control, cohort and twin studies. The effect is strongest among first-degree relatives, where the relati...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Study families were required to meet at least one of the following criteria:
- Have three or more first-degree relatives with PC
- Have three generations with PC, either through paternal or maternal lineage; or
- Have two-first degree relatives with PC diagnosed before age 65 or who were African American. All surviving men, and selected unaffected men and females were invited to join.
Exclusion
Key Trial Info
Start Date :
November 8 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2018
Estimated Enrollment :
5118 Patients enrolled
Trial Details
Trial ID
NCT00342784
Start Date
November 8 2004
End Date
July 30 2018
Last Update
August 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892